Eloxx Pharmaceuticals Inc (ELOX)
0.855
-0.04
(-5.00%)
USD |
OTCM |
May 06, 15:24
Eloxx Pharmaceuticals Max Drawdown (5Y): 99.89% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| April 30, 2024 | 99.89% |
| March 31, 2024 | 99.89% |
| February 29, 2024 | 99.89% |
| January 31, 2024 | 99.89% |
| December 31, 2023 | 99.89% |
| November 30, 2023 | 99.81% |
| October 31, 2023 | 99.81% |
| September 30, 2023 | 99.81% |
| August 31, 2023 | 99.81% |
| July 31, 2023 | 99.81% |
| June 30, 2023 | 99.81% |
| May 31, 2023 | 99.81% |
| April 30, 2023 | 99.81% |
| March 31, 2023 | 99.81% |
| February 28, 2023 | 99.81% |
| January 31, 2023 | 99.81% |
| December 31, 2022 | 99.81% |
| November 30, 2022 | 99.52% |
| October 31, 2022 | 99.43% |
| September 30, 2022 | 99.36% |
| August 31, 2022 | 99.04% |
| July 31, 2022 | 98.97% |
| June 30, 2022 | 98.97% |
| May 31, 2022 | 98.88% |
| April 30, 2022 | 98.59% |
| Date | Value |
|---|---|
| March 31, 2022 | 98.28% |
| February 28, 2022 | 98.23% |
| January 31, 2022 | 98.11% |
| December 31, 2021 | 97.32% |
| November 30, 2021 | 97.19% |
| October 31, 2021 | 94.76% |
| September 30, 2021 | 94.76% |
| August 31, 2021 | 94.76% |
| July 31, 2021 | 94.41% |
| June 30, 2021 | 94.20% |
| May 31, 2021 | 94.20% |
| April 30, 2021 | 93.30% |
| March 31, 2021 | 93.30% |
| February 28, 2021 | 93.30% |
| January 31, 2021 | 93.30% |
| December 31, 2020 | 93.30% |
| November 30, 2020 | 93.30% |
| October 31, 2020 | 93.30% |
| September 30, 2020 | 93.30% |
| August 31, 2020 | 93.30% |
| July 31, 2020 | 93.30% |
| June 30, 2020 | 93.30% |
| May 31, 2020 | 93.30% |
| April 30, 2020 | 93.30% |
| March 31, 2020 | 91.58% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
69.15%
Minimum
May 2019
99.89%
Maximum
Dec 2023
94.10%
Average
95.97%
Median
Max Drawdown (5Y) Benchmarks
| NovaBay Pharmaceuticals Inc | 99.91% |
| Palatin Technologies Inc | 96.46% |
| iBio Inc | 99.97% |
| Theriva Biologics Inc | 99.81% |
| Oragenics Inc | 98.92% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -103.35 |
| Beta (5Y) | 2.709 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 129.5% |
| Historical Sharpe Ratio (5Y) | -0.5648 |
| Historical Sortino (5Y) | -1.224 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 50.17% |